IL17A and psoriasis vulgaris: Overall, SLK was well-tolerated, with those AEs observed consistent with the inhibition of IL-17 family cytokines and previously reported clinical trials of SLK in plaque psoriasis and hidradenitis suppurativa35,37,60–62.